Skip to main content
AAWH
OTC Life Sciences

Ascend Wellness Q3 Revenue Grows 4.2% to $130M; Net Loss Widens to $28M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.35
Mkt Cap
$71.186M
52W Low
$0.34
52W High
$1.2
52W Position info
3.2% above low
Off High info
71% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

AAWH is trading near its 52-week low of $0.34 (3.2% above the low).

Summary

Ascend Wellness posted Q3 2026 revenue of $130.0 million, up 4.2% year-over-year, with Adjusted EBITDA of $31.1 million, but the net loss widened to $28.0 million as interest expense climbed to $22.0 million. The company ended the quarter with $63.6 million in cash against $260.4 million of net debt.


Key Events · Earnings and Guidance · AAWH

  • Q3 Revenue Returns to Growth

    Net revenue was $130.0 million, up 3.1% sequentially from $126.1 million and 4.2% year-over-year from $124.7 million, driven by retail revenue of $97.8 million (up 5.5% sequentially).

  • Net Loss Widens to $28.0M

    Net loss was $28.0 million versus $9.8 million in Q2 2026, which had included a one-time $14.8 million release from the reserve for uncertain tax positions. Interest expense rose to $22.0 million from $12.6 million a year earlier.

  • Cash Flow Positive After Interest Payment

    Operating cash flow was $5.4 million even after the $19.1 million semi-annual interest payment, a $7.4 million improvement from Q3 2025; free cash flow was $2.7 million and capital expenditures were $4.8 million.

  • Balance Sheet Remains Levered

    Cash and cash equivalents were $63.6 million at September 30, 2026, against net debt of $260.4 million and total stockholders' deficit of $112.4 million.


Analysis · AAWH · Life Sciences

Revenue returned to year-over-year growth and Adjusted EBITDA held at $31.1 million, but the bottom line deteriorated sharply: net loss widened to $28.0 million from $9.8 million in Q2, which had benefited from a one-time $14.8 million tax reserve release. Interest expense nearly doubled year-over-year to $22.0 million, and with $260.4 million of net debt against a $63.6 million cash balance, debt service is the dominant constraint on the equity. Even after a $19.1 million semi-annual interest payment, the company generated $5.4 million of operating cash flow, and it exceeded its 60-store target with 61 locations open. Q4 guidance calls for only 1-2% revenue growth with margins flat to Q3.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AAWH was trading at $0.35 on OTC in the Life Sciences sector, with a market capitalization of approximately $71.2M. The 52-week trading range was $0.34 to $1.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AAWH - Latest Insights

AAWH
Nov 12, 2026, 5:11 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.3503
Real-time Price: $0.3411 info
Change: -$0.0092 (-3%) info
Market Cap: $69.316M info
AAWH
Aug 12, 2026, 5:13 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.415
Real-time Price: $0.3411 info
Change: -$0.0739 (-18%) info
Market Cap: $69.316M info
AAWH
Aug 12, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.415
Real-time Price: $0.3411 info
Change: -$0.0739 (-18%) info
Market Cap: $69.316M info
AAWH
Jul 09, 2026, 5:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.410
Real-time Price: $0.3411 info
Change: -$0.0689 (-17%) info
Market Cap: $69.316M info
AAWH
Jun 25, 2026, 4:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4475
Real-time Price: $0.3411 info
Change: -$0.1064 (-24%) info
Market Cap: $69.316M info